SciELO - Scientific Electronic Library Online

 
vol.26 número1Factor de crecimiento epidérmico en el tratamiento de la proctitis radiógenaEspectroscopía de impedancia electroquímica, herramienta eficaz para el diagnóstico rápido microbiológico índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Biotecnología Aplicada

versão On-line ISSN 1027-2852

Resumo

BLANCO, Lisette et al. Neuroprotective effect of the systemic administration of MK-801 on the pedunculopontine nucleus of hemiparkinsonian rats . Biotecnol Apl [online]. 2009, vol.26, n.1, pp. 59-64. ISSN 1027-2852.

Glutamatergic antagonists were administered in rats, as part of the current pharmacological therapies for neuroprotection of patients with Parkinson disease, due to glutamatergic hyperactivity and the deleterious effects of this condition. The effect of the systemic administration of MK-801, an antagonist of N-methyl-D-aspartate (NMDA) receptors, was evaluated on the extracellular concentrations of glutamate (Glu) and gamma amino butyric acid (GABA), loss of dopaminergic cells and cell death in the pedunculopontine nucleus (PPN) of hemiparkinsonian rats. Five treatments were studied in Wistar rats: lesion in the substantia nigra pars compacta (SNpc) with 6- hydroxydopamine (6-OHDA)(n = 15); 6-OHDA lesion plus the systemic administration of MK-801 (0.5 mg/kg; n = 17); false lesion in the SNpc (n = 10), false lesion in the SNpc plus false systemic treatment (n = 10) and no treatment (n = 22). The extracellular concentrations of Glu and GABA were analyzed by cerebral microdialysis and high performance liquid chromatography coupled to fluorometric detection. The loss of dopaminergic cells and cell death processes in the PPN were assessed by immunohistochemistry for tyrosine hydroxylase and the TUNEL technique, respectively. The extracellular concentrations of Glu and GABA significantly decreased in the PPN after the MK-801 treatment, compared to untreated hemiparkinsonian rats. This treatment caused a decreased loss of dopaminergic cellular bodies in the tegmental ventral area of rats and prevented cell death in the PPN of hemiparkinsonian rats. These results suggest a neuroprotective effect mediated by a decreased glutamatergic tone in hemiparkinsoninan rats systemically treated with an antagonist of NMDA receptors.

Palavras-chave : MK-801; pedunculopontine nucleus; Parkinson disease; 6-OHDA.

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )